PERSPECTIVE THERAPEUTICS, INC. (CATX) Debt Components
- 2026-06-30: Notes Payable, CurrentUSD $57.00K; Long-term DebtUSD $1.60M; Commercial Paper, at Carrying ValueUSD $0.00; Long-Term Debt, Maturity, Year OneUSD $1.57M.
- 2026-03-31: Notes Payable, CurrentUSD $56.00K; Long-term DebtUSD $1.61M; Commercial Paper, at Carrying ValueUSD $0.00; Long-Term Debt, Maturity, Year OneUSD $1.57M.
- 2025-12-31: Notes Payable, CurrentUSD $56.00K; Long-term DebtUSD (m); Commercial Paper, at Carrying ValueUSD $2.49M; Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-12-31: Notes Payable, CurrentUSD (m); Long-term DebtUSD $1.62M; Commercial Paper, at Carrying ValueUSD (m); Long-Term Debt, Maturity, Year OneUSD $56.00K.
PERSPECTIVE THERAPEUTICS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Notes Payable, Current USD | Long-term Debt USD | Commercial Paper, at Carrying Value USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Notes Payable USD | Long-Term Debt, Maturity, Year Four USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $57.00K | $1.60M | $0.00 | $1.57M | (m) | (m) | $28.00K | (m) | (m) |
| 2026-03-31 | $56.00K | $1.61M | $0.00 | $1.57M | (m) | (m) | $41.00K | (m) | (m) |
| 2025-12-31 | $56.00K | (m) | $2.49M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $1.62M | (m) | $56.00K | $1.57M | (m) | (m) | (m) | (m) |
| 2025-09-30 | $55.00K | $1.64M | (m) | $56.00K | $1.57M | (m) | $13.00K | (m) | (m) |
| 2025-06-30 | $54.00K | $1.65M | (m) | $56.00K | $1.57M | (m) | $26.00K | (m) | (m) |
| 2025-03-31 | $53.00K | $1.66M | (m) | $56.00K | $1.57M | (m) | $39.00K | (m) | (m) |
| 2024-12-31 | $52.00K | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $1.68M | (m) | $52.00K | $56.00K | $1.57M | (m) | (m) | (m) |
| 2024-09-30 | $51.00K | $1.69M | (m) | $52.00K | $55.00K | $1.57M | $13.00K | (m) | (m) |
| 2024-06-30 | $54.00K | $1.71M | (m) | $52.00K | $55.00K | $1.57M | $29.00K | (m) | (m) |
| 2024-03-31 | $50.00K | $1.71M | (m) | $52.00K | $55.00K | $1.57M | $37.00K | (m) | (m) |
| 2023-12-31 | $49.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $1.73M | (m) | $49.00K | $52.00K | $55.00K | (m) | (m) | $1.57M |
| 2023-09-30 | $48.00K | $1.74M | (m) | $49.00K | $52.00K | $55.00K | $12.00K | $1.74M | $1.57M |
| 2023-06-30 | $71.00K | $1.77M | (m) | $49.00K | $52.00K | $55.00K | $47.00K | $1.77M | $1.57M |
| 2023-03-31 | $80.00K | $1.79M | (m) | $49.00K | $52.00K | $55.00K | $68.00K | $1.79M | $1.57M |
| 2022-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |